Liquidia Corp.
(NASDAQ : LQDA)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc. 1.84%37.200.9%$1872.43m
ABBVAbbVie, Inc. 0.71%104.941.9%$1090.97m
JNJJohnson & Johnson 0.29%144.090.7%$1080.34m
BMYBristol-Myers Squibb Co. 0.59%63.211.0%$716.46m
MRKMerck & Co., Inc. -0.33%79.800.7%$691.89m
LLYEli Lilly & Co. 1.53%146.971.1%$689.63m
AZNAstraZeneca Plc -0.37%52.411.2%$287.27m
GSKGlaxoSmithKline Plc -0.44%37.070.2%$233.58m
NVSNovartis AG 0.20%89.360.2%$179.80m
NVONovo Nordisk A/S 2.10%67.530.1%$96.45m
RGENRepligen Corp. 1.89%184.867.1%$94.47m
SNYSanofi 1.71%51.060.2%$76.55m
ARCTArcturus Therapeutics Holdings, Inc. 26.07%76.440.0%$72.68m
RPRXRoyalty Pharma Plc 1.98%41.780.2%$67.63m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. 1.43%90.910.0%$67.51m

Company Profile

Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC.